Work Area: Transactions

Latest content

Pfizer’s $2.3 billion spend on CD47 inhibitors shows how oncology IP continues to drive pharma deal-making

The acquisition of the cutting-edge haematology candidates is just the latest development in the booming immuno-oncology market

26 August 2021

Meet the people who make the global patent transactions market tick

The Long Read: Grounded at home and facing an uncertain business environment, IP business leaders still found ample opportunity to make innovative deals during the covid pandemic. Today, we name the individuals sitting in places 40 down to 11 in this year's IAM Market Makers ranking

25 August 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other legal practice areas - becomes a Law Business Research company

25 August 2021

Toyota’s self-driving haul from Lyft includes 100+ US patent assets

Patents change hands after Japanese carmaker buys Lyft’s self-driving tech for $550 million

23 August 2021

Panasonic is the latest HEVC heavy hitter to join Access Advance

Japanese electronics giant becomes first member of rival platform Velos Media to make its assets available through Access Advance

16 August 2021

mRNA IP will be hot property beyond the pandemic

$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field

12 August 2021

Taiwan foundry sells off hundreds of rights in latest big chip patent deal

UMC returns for its first outbound transaction in several years, dealing portfolio to a new Ireland-based NPE

09 August 2021

Ofinno still has a lot of high-quality patents to offer after sell-offs to major innovators

The Virginia-based R&D outfit counts Honda, Xiaomi, Comcast, Samsung and Huawei among its customers

06 August 2021

Healthcare Royalty Partners’ $750 million IPO to be next milestone for a booming market

The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams

05 August 2021

Investor interest in IP is about more than big money verdicts, claims Ocean Tomo transactions chief

Ten-figure awards in the patent space have caught capital’s attention, says Ocean Tomo's Ryan Zurek, but so has the IP market’s resilience in the face of economic turbulence

04 August 2021

Get unlimited access to all IAM content